Tardive Dyskinesia Symptoms: Early Signs on Antipsychotics

Maybe someone asked why you keep chewing when you aren’t eating. Or you caught your tongue moving in the mirror and weren’t sure if you’d always done that. When you’re taking a medication that’s helping your mood, a new movement like that can be easy to brush off, and scary to bring up.

Your brain uses dopamine for more than mood and motivation. It also helps run the circuits deep in your brain that keep your movements smooth and intentional. Antipsychotics work partly by blocking dopamine receptors, and a BMJ Neurology review notes that this blockade is a cause of tardive dyskinesia, even though the full mechanism isn’t simple. Catching it early takes precision, because the first movements are often small enough to miss.

Newer antipsychotics were a real step forward here. A World Psychiatry meta-analysis of 57 head-to-head trials found the yearly rate of new tardive dyskinesia was 2.6% with second-generation antipsychotics, compared with 6.5% with older ones. The results are real, and the science is well established.

But lower risk is still risk, and at Siggy we believe anyone taking these medications deserves to know the early signs before they become hard to reverse.

That matters beyond schizophrenia. Antipsychotics such as aripiprazole are also prescribed as add-on treatment for depression, so many people with mood conditions are taking a medication that carries this warning.

What This Page Covers

• What Is Tardive Dyskinesia?
• What Are the Early Signs of Tardive Dyskinesia?
• How Is Tardive Dyskinesia Different From Other Movement Side Effects?
• Who Is Most at Risk?
• How Is Tardive Dyskinesia Checked?
• Is Tardive Dyskinesia Reversible?
• How Is Tardive Dyskinesia Treated?
• When to Get Help Right Away
• How Siggy Fits In
• The Bottom Line on Tardive Dyskinesia Symptoms
• Start Your Anonymous Intake

What Is Tardive Dyskinesia?

Tardive dyskinesia (TD) is a movement disorder that causes repetitive, involuntary movements. “Tardive” means late, because it tends to show up after longer exposure to a medication. The KINECT 3 trial describes it as a persistent movement disorder caused by drugs that block dopamine receptors, including antipsychotics.

It’s more common than many people realize. A 2017 prevalence meta-analysis of 41 studies covering more than 11,000 people found tardive dyskinesia in 25.3% of those taking antipsychotics. Rates were lower with current second-generation antipsychotics (20.7%) than with first-generation ones (30.0%). The authors noted that most studies didn’t report severity well, so it’s hard to say how many of these cases were clinically significant.

It’s also likely underdiagnosed. In a 2026 claims analysis of more than 729,000 adults with mental health diagnoses taking antipsychotics, only 0.57% had a recorded TD diagnosis in 2022, and the authors concluded that TD remains underdiagnosed.

What Are the Early Signs of Tardive Dyskinesia?

A 2023 movement review describes “classic” tardive dyskinesia as repetitive movements of the mouth, cheeks, and tongue. In everyday terms, early signs can look like:

• Tongue movements, such as pushing against the cheek or darting out of the mouth
• Lip smacking, puckering, or pursing
• Chewing or jaw movements when you aren’t eating
• Grimacing or other facial movements
• Finger or toe movements, like tapping or curling
• Rocking, swaying, or twisting of the trunk

The same review notes TD can also come with twisting postures (dystonia), restlessness, and other movement types. A 2015 pharmacogenetics review adds that TD mostly affects the mouth, cheeks, and tongue, with limb and trunk involvement usually less severe.

Early movements can be subtle, so asking a partner, friend, or family member whether they’ve seen anything new is a simple, useful check.

How Is Tardive Dyskinesia Different From Other Movement Side Effects?

Antipsychotics can cause several movement side effects, and timing is the biggest clue. The 2023 review groups them into acute problems that start within minutes to days of starting or raising a dose, and tardive problems that appear after longer exposure or within weeks of stopping.

Side Effect	Typical Timing	What It Looks Like
Acute dystonia	First few days	Muscle spasms, often neck, jaw, or tongue
Akathisia	Soon after start or dose increase	Restlessness, hard to stay still
Drug-induced parkinsonism	Soon after start or dose increase	Slowed movement, stiffness
Tardive dyskinesia	After longer use, or after stopping	Repetitive mouth, face, or limb movements

The dystonia details come from the Abilify prescribing information, which describes neck spasms, throat tightness, and tongue protrusion in the first few days of treatment. That label also shows why akathisia deserves attention in depression care: in the add-on depression trials, akathisia was reported by 25% of people taking aripiprazole versus 4% on placebo.

Who Is Most at Risk?

A 2018 risk-factor review sorts TD risk factors into those you can’t change and those you sometimes can.

Factors you can’t change include older age, female sex, longer illness duration, and having a mood disorder. Factors that may be modifiable include diabetes, smoking, alcohol or substance use, taking an older antipsychotic, higher current or cumulative doses, early parkinsonism side effects, akathisia, and taking anticholinergic medications alongside an antipsychotic.

The Abilify label adds important context. It says TD prevalence appears highest among older adults, especially older women, and that the risk and the chance it becomes permanent are believed to rise with longer treatment and higher total dose. It also notes TD can develop, though much less commonly, after relatively brief treatment at low doses.

Newer antipsychotics lower the risk on average, but not every study agrees. The World Psychiatry authors noted that two large trials, CATIE and CUtLASS, gave the impression of no difference between older and newer drugs. One reason they discussed is that the older-drug group in CUtLASS mostly took sulpiride, a drug with an unusually low risk of movement side effects.

How Is Tardive Dyskinesia Checked?

A common tool is the Abnormal Involuntary Movement Scale (AIMS), a structured exam in which a clinician observes and rates involuntary movements in different parts of the body. It’s also the main outcome measure in TD treatment trials.

A 2022 nursing review says everyone taking antipsychotics should be monitored regularly for TD, and that evaluation can be done successfully over telehealth using structured best practices. If you take an antipsychotic and can’t remember the last time someone checked your movements, it’s reasonable to ask.

Is Tardive Dyskinesia Reversible?

Sometimes. The Abilify label calls TD potentially irreversible, but notes it may remit, partially or completely, if the antipsychotic is withdrawn. The label also explains that antipsychotics can partly suppress TD movements, which can hide the underlying problem until the dose is lowered or stopped.

That’s why early detection matters. Because the chance of permanence is believed to rise with longer treatment and higher total dose, noticing movements sooner gives you and your prescriber more room to act.

How Is Tardive Dyskinesia Treated?

Treatment usually starts with your prescriber reviewing whether the antipsychotic is still needed, whether the dose can be lowered, or whether a switch makes sense. Never make those changes on your own, because the condition the medication treats still needs care, and any change should be planned.

A major advance is a class of drugs called vesicular monoamine transporter 2 (VMAT2) inhibitors. As the 2026 claims analysis notes, valbenazine (Ingrezza) and deutetrabenazine (Austedo) are the only FDA-approved medications for TD.

The trial results are meaningful but modest in size:

• In KINECT 3, valbenazine 80 mg reduced AIMS scores by 3.2 points over 6 weeks, compared with 0.1 on placebo. The trial included people with mood disorders, and most kept taking their antipsychotic.
• In the AIM-TD deutetrabenazine trial, deutetrabenazine 24 mg and 36 mg reduced AIMS scores by 3.2 and 3.3 points over 12 weeks, compared with 1.4 on placebo, with side effect rates similar to placebo.

Setting expectations matters. The 2018 risk-factor review notes that most patients on VMAT2 inhibitors don’t fully remit and that TD tends to return when treatment is stopped.

One habit to question: anticholinergic drugs like benztropine are used for some acute side effects, but the 2018 risk-factor review lists anticholinergic co-treatment among the factors linked to TD.

When to Get Help Right Away

Most TD develops slowly and calls for a prompt appointment, not an emergency room. A few movement-related symptoms are different. Call 911 if you have:

• Throat tightness, trouble swallowing, or trouble breathing, especially in the first few days of a new medication, which the Abilify label lists among dystonia symptoms
• High fever with severe muscle stiffness and confusion, which can signal neuroleptic malignant syndrome, a rare emergency described on the same label

If you’re having thoughts of harming yourself, call or text 988.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions. If an antipsychotic is part of your treatment, the prescriber managing it is the right first call for any new movements. Siggy’s intake gathers structured information, including every medication you take, and it doesn’t diagnose you on its own. A licensed prescriber reviews your intake before anything is prescribed or changed.

The anonymous intake asks for no name, email, or account, and you’ll get a downloadable summary you can share with any clinician. That can help when your care is spread across more than one prescriber, because the person checking your movements should know everything you take.

Siggy isn’t an emergency service. If you’re in crisis, call 911 or call or text 988. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

The Bottom Line on Tardive Dyskinesia Symptoms

Tardive dyskinesia usually starts small, often as movements of the tongue, lips, or jaw, after longer-term use of an antipsychotic. It affects roughly 1 in 4 people taking these medications in pooled studies, and it’s likely underdiagnosed. Regular movement checks, honest conversations about dose and need, and VMAT2 inhibitors when appropriate give you real options. If you take an antipsychotic for depression or another condition, our guides to Abilify side effects and Rexulti side effects cover what else to watch for.

Start Your Anonymous Intake

If you’re in crisis right now, call 911 or call or text 988 first. If you want a clear picture of every medication you take and what to watch for, start your anonymous intake. It’s free, there’s no name or email required, and a licensed prescriber reviews your intake before anything is prescribed. Your summary is yours to keep and share with whoever helps you next.